Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prajna Anirvan

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Journal of Clinical and Experimental Hepatology|May 30, 2023
INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLDShivaram P Singh, Ajay Duseja, Mamun Al Mahtab, et al.
Journal of Clinical and Experimental Hepatology|February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) StudyNarendra S Choudhary, Ajay Duseja, Arka De, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Journal of Clinical and Experimental Hepatology|May 30, 2023
INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLDShivaram P Singh, Ajay Duseja, Mamun Al Mahtab, et al.
Journal of Clinical and Experimental Hepatology|February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) StudyNarendra S Choudhary, Ajay Duseja, Arka De, et al.
Pageof 6